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Abstract
Background: The causes of female infertility are multifactorial and necessitate comprehensive evaluation including
physical examination, hormonal testing, and imaging. Given the associated psychological and financial stress that
imaging can cause, infertility patients benefit from a structured and streamlined evaluation. The goal of such a work
up is to evaluate the uterus, endometrium, and fallopian tubes for anomalies or abnormalities potentially
preventing normal conception. To date, the standard method for assessing these structures typically involves some
combination of transvaginal sonography (TVS), hysterosalpingography (HSG), and hysteroscopy (HSC). The goal of
this review is to compare the diagnostic accuracy of TVS, HSG, and HSC for diagnosing abnormalities in infertility
patients to determine if all studies are necessary for pre-treatment evaluation.
Results: We identified infertility patients prior to initiation of assisted reproductive technology who had baseline TVS,
HSG, and HSC within 180 days of each other. From medical record review, we compared frequencies of each finding
between modalities. Of the 1274 patients who received a baseline TVS over 2 years, 327 had TVS and HSG within
180 days and 55 patients had TVS, HSG and HSC. Of the 327, TVS detected fibroids more often than HSG (74 vs. 5,
p < .0001), and adenomyosis more often than HSG (7 vs. 2, p = .02). HSG detected tubal obstruction more often than
TVS (56 vs. 8, p = .002). Four (1.2 %) patients had endometrial polyps on both HSG and TVS.
In the 55 patients with HSG, TVS, and HSC, HSC identified endometrial polyps more often than TVS (10 vs. 1, p = .0001)
and HSG (10 vs. 2, p = .0007). TVS detected more fibroids than HSC (17 vs. 5, p < .0001). Tubal obstruction was identified
more often by HSG than HSC (19 vs. 5, p < .0001).
Conclusions: TVS is superior for evaluation of myometrial pathology. HSG is superior for evaluation of tubal pathologies.
Endometrial pathologies are best identified with HSC.
Keywords: Infertility, Transvaginal sonography, Hysterosalpingography
Background
Infertility is defined as the inability for a couple to con-
ceive a pregnancy following 1 year of unprotected vagi-
nal intercourse [1]. It is estimated that 10–15 % of
couples seek treatment for infertility [1–3]. It is generally
considered appropriate to evaluate a couple for causes of
infertility after 1 year of failed attempts at conception.
However, given the inverse relationship of female fertility
with age, it is often recommended that women over
35 years of age be evaluated after 6 months of failure to
conceive, and women older than 40 be evaluated imme-
diately [1].
A variety of factors may affect normal fertility includ-
ing patient age, anatomy, ovulatory status, and sperm
quality. Potential causes of infertility can be divided into
male and female causes and include endocrine, ana-
tomic, genetic, and behavioral conditions [4]. As a result,
the evaluation of the infertile couple is multifactorial,
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necessitating physical examination, hormonal testing, and
imaging. Because the infertility population is under a great
deal of psychological and emotional stress, these patients
benefit from a structured and streamlined evaluation. In
particular, evaluation of the female partner attempting to
conceive requires assessment of the uterus, endometrium,
and fallopian tubes for anomalies or abnormalities poten-
tially preventing normal conception. The best method for
assessing these structures usually involves some combin-
ation of transvaginal sonography (TVS), hysterosalpingog-
raphy (HSG), and hysteroscopy (HSC). Less often, pelvic
magnetic resonance imaging (MRI) and saline infusion
sonohysterography (SIS) are used.
The objective of this paper is to compare the diagnos-
tic accuracy of TVS, HSG, and HSC for diagnosing uter-
ine and tubal abnormalities in women with infertility to
determine if all three modalities are necessary in the
work up of these patients.
Methods
We identified all baseline TVS performed on women in
our infertility program from October 12, 2011 to October
12, 2013, prior to their initiation of assisted reproductive
techniques (ART). From this group, we narrowed our pa-
tient population to those who had an HSG within 180 days
of the TVS to maximize the likelihood of concordance
between the studies. All TVS and HSG reports were
reviewed for tubal, myometrial, or endometrial findings
and anatomical variants.
We reviewed patient medical records to identify those
patients who also had hysteroscopy (HSC) within 180 days
of the baseline TVS, and we recorded the reported
findings.
Myometrial abnormalities were categorized as fibroids
or adenomyosis; endometrial abnormalities as polyps,
cysts, cavity distortion (e.g., synechia, stricture), or non-
specific asymmetry; and tubal abnormalities as obstruc-
tion. For each abnormality, the frequency of detection
by each modality (TVS, HSG, HSC) was tabulated. For
TVS, visualization of a hydrosalpinx was classified as an
obstructed fallopian tube. Detection rates of abnormal-
ities were compared among the modalities using the
Fisher exact test, with a p-value of <0.05 considered
significant.
This study was approved by the Brigham and Women’s
Hospital Institutional review board, protocol number
2014P000355.
Results
A total of 1274 patients received a baseline TVS as part
of a work up for infertility during the study period.
Among these patients, 327 underwent a diagnostic HSG
within a 180-day interval of the sonogram and comprise
our study population. The time between TVS and HSG
was 94 ± 49 days (mean ± SD). Among our 327 study pa-
tients, 55 also underwent HSC. The time (mean ± SD)
between TVS and HSC was 61 ± 41 days and between
HSG and HSC was 61 ± 50 days.
Among the study population of 327 patients (Table 1), 74
(23 %) had fibroids and 7 (2 %) had adenomyosis as diag-
nosed by either modality. Endometrial abnormalities were
found in 16 (5 %) patients, based on TVS or HSG. Tubal
obstruction was found in 56 (17 %) patients, more com-
monly unilateral (47 patients) than bilateral (9 patients).
TVS detected myometrial abnormalities significantly
more often than did HSG, identifying fibroids in 74 pa-
tients while HSG only identified 5 (Fig. 1), and detecting
adenomyosis in 7, while HSG detected only 2 (p < .0001
for both comparisons). Both HSG and TVS diagnosed
endometrial polyps in the same 4 patients. HSG detected
6 patients with cavity distortion, while TVS found none
of these (p < 0.002). With respect to tubal abnormalities,
HSG performed significantly better than TVS, detecting
tubal obstruction in all 56 (Fig. 2), while ultrasound only
diagnosed 8 (p < .0001) (Fig. 3).
Among the subset of 55 patients who were evaluated
by all three modalities, TVS, HSG, and HSC (Table 2),
17 (31 %) had fibroids and 6 (11 %) had adenomyosis.
Endometrial abnormalities were found in 13 (24 %) pa-
tients and tubal obstruction in 19 (35 %).
In this group, TVS detected myometrial abnormalities
significantly more often than did HSC, which identified
only 4 of the 17 patients with fibroids (p < .0001) and
none of the patients with adenomyosis. With respect to
endometrial abnormalities, HSC outperformed TSV and
HSG, identifying 10 polyps, while TVS only detected 1
Table 1 Myometrial, endometrial, and tubal abnormalities
detected by transvaginal ultrasound and/or
hysterosalpingography (N = 327)
Category TVS HSG Statistical significance
Myometrium
Fibroids 74 (23 %) 5 p < .0001
Adenomyosis 7 (2 %) 2 p < .0001




Cavity distortion 0 6 p < 0.002
Nonspecific asymmetry 0 2
Tubes




Abbreviations: TVS transvaginal ultrasound, HSG hysterosalpingography
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(p = .0001) and HSG only 2 (p = .0007). HSG outper-
formed HSC for tubal obstruction, which only detected
5 of the 19 patients with unilateral or bilateral obstruc-
tion (<0.0001)
Discussion
Diagnostic imaging plays an important role in the as-
sessment of women with infertility. Although no consen-
sus protocol for work up of these patients exists, the
majority of infertility patients undergo a baseline TVS
and HSG. TVS is used for evaluating ovaries, fallopian
tubes, and the adnexa and is a favored imaging modality
in the infertility population because it is readily available,
relatively low cost, and does not use ionizing radiation.
TVS is the test of choice for diagnosing polycystic ovary
syndrome [5], and is helpful for identifying endometri-
osis and the sequelae of PID. In addition, TVS is invalu-
able for monitoring ovarian folliculogenesis during
treatment with ART [6–8]. In contrast, HSG provides
information about tubal patency and uterine cavity ab-
normalities such as anomalies, polyps, synechiae, and
adhesions, any of which could interfere with embryo im-
plantation [9]. However, HSG offers limited evaluation
of the cervix and myometrium and does carry the small
risks of contrast reaction and of ionizing radiation ex-
posure [10]. Besides TVS and HSG, supplemental evalu-
ation with SIS and hysterosalpingo-contrast sonography
(HyCoSy) is sometimes performed. These imaging pro-
cedures are becoming more popular because of their
ability to combine TVS adnexal evaluation with HSG-
like assessment of the uterine cavity, without the risks of
contrast reactions and radiation exposure [11–13], but
are not yet universally available.
MRI of the pelvis offers multi-planar imaging and does
not require the use of ionizing radiation. It is an excel-
lent modality for detecting endometriosis [5] and is
helpful for determine the nature of uterine duplication
anomalies, leiomyomas, and adenomysis [14–18]. MRI is
also employed for evaluating intracranial causes of infer-
tility, such as pituitary adenomas. However, due to its
high cost and limited access, MRI is not typically used in
the infertility assessment except for a specific indication
requiring such imaging.
Fig. 1 a 38-year-old G1P1 female with a history of infertility presenting for baseline assessment prior to initiation of ART. Coronal transvaginal
sonographic image through the uterus demonstrates a 6.0 × 4.2 × 3.9 cm left sided mass with heterogenous echotexture and an echogenic rim,
consistent with a large calcified intramural fibroid. b HSG demonstrates a normal endometrial cavity without filling defects to suggest fibroids as
seen on TVS. The fallopian tubes are normal in caliber and demonstrate free intraperitoneal spill of contrast bilaterally
Fig. 2 36 year-old G2P1A1 female with a history of infertility ×
3 years, presenting for baseline assessment of tubal patency prior to
initiation of ART. HSG demonstrates normal contour of the endometrial
cavity. The left fallopian tube opacifies normally and demonstrates free
intraperitoneal spill. The right fallopian tube fills with contrast, but
terminates abruptly near its terminus (arrowhead). No right sided
contrast spill is identified, diagnostic of distal tubal obstruction. This
tubal obstruction was not appreciated on TVS or HSC
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At our institution, we begin the infertility assessment
with an HSG. If there is evidence of an abnormal uterine
cavity from etiologies such as uterine septa, submucosal
fibroids, synchiae, or polyps, HSC is then typically per-
formed [19–21]. The standard practice at our institution
is to perform HSC in the office setting, reserving opera-
tive HSC and laparoscopy for patients who are not able
to tolerate office based procedures and for situations for
which surgical correction is required, such as septoplasty
for the correction of a subseptate uterus. Hysteroscopy
is also preformed prior to ART if there is a 6 month or
greater delay between the HSG and ART. TVS is ob-
tained when patients begin ART, and continues during
folliculogensis.
Our results indicate that TVS is superior to HSG for
detection of myometrial pathology, including fibroids
and adenomyosis. These results make intuitive sense, as
TVS uses high frequency sound waves to evaluate the 3
dimensional volume and echotexture of the uterine tis-
sue, while HSG uses radiographs and contrast dye to
outline the endometrial cavity. By assessing the contour
of the contrast-filled cavity, information about the sur-
rounding myometrium can be inferred, but not diag-
nosed, because the tissue itself is not imaged directly.
HSG may detect submucosal fibroids, but other myome-
trial pathology, such as intramural or subserosal fibroids,
are likely to be missed. Similarly, TVS is superior to
HSC, which visualizes the walls of the uterine cavity but
cannot assess for lesions within the myometrium.
Our results also indicate that HSG is the superior mo-
dality for detection of tubal pathology, specifically tubal
obstruction. This finding is in keeping with the functional
component of HSG, which allows the operator to visualize
in real-time contrast medium passing through the tubes
and most importantly, spilling into the surrounding peri-
toneum. TVS can only infer tubal obstruction when a
Fig. 3 a 38-year-old G2P2 female with history of male factor infertility presenting for baseline assessment prior to initiating ART. Transvaginal
grey-scale image of the left adnexa demonstrates an anechoic tubular structure (calipers), measuring 43 × 31 × 19 mm, separate from the left
ovary (not shown) and consistent with hydrosalpinx. b HSG demonstrates contrast pooling within a dilated, blind ending fallopian tube (arrows),
confirming the presence of a left sided hydrosalpinx. The right fallopian tube is normal in caliber and demonstrates free intraperitoneal spill of
contrast, indicating tubal patency
Table 2 Myometrial, endometrial, and tubal abnormalities
detected by each modality (N = 55)
Category TVS HSG HSC Statistical
significance
Myometrium
Fibroids 17 (31 %) 6 4 p < .0001
(TVS vs HSC)
Adenomyosis 6 (11 %) 0 0
Endometrium
Polyps 1 2 10 p = .0001
( HSC vs TVS)
p = .0007
(HSC vs HSG)
Cysts 1 0 0
Cavity distortion 0 4 2
Nonspecific asymmetry 0 2 1
Tubes
Total Obstructed 6 19 (35 %) 5 <0.0001
(HSG vs HSC)
Unilateral 6 16 5
Bilateral 0 3 0
Anomalies 0 1 31
Abbreviations: TVS transvaginal ultrasound, HSG hysterosalpingography,
HSC hysteroscopy
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hydrosalpinx is present, therefore obstructed but nondis-
tended fallopian tubes will be missed with sonography
alone. Endometrial pathologies, specifically endometrial
polyps, were more frequently identified on direct
visualization with HSC than on TVS and HSG combined.
It is possible that, for some of our patients, the HSC pre-
ceded the TVS and/or HSG and, thus, polyps could have
been removed by the time of imaging evaluation. While
TVS and HSG are both potential screening modalities for
endometrial lesions, HSC is required for optimal diagnosis
(Fig. 4), and one reason why flexible office hysteroscopy
remains the gold standard for endometrial assessment.
A weakness in our study is that we did not assess SIS as
a method to evaluate the endometrium. This procedure is
included in some protocols during the work up of women
with infertility, but is not part of the routine assessment at
our institution. SIS has been shown to be superior to TVS
for identifying endometrial abnormalities including polyps
and cavity distortion [11, 13, 22–27]. Some reports have
also shown SIS to be comparable to the gold standard of
HSC for evaulation of intrauterine abnormalities including
polyps, submucosal fibroids, adhesions and uterine anom-
alies, with a sensitivity and specificity for detection of 88
and 94 %, respectively [28, 29]. In addition, none of our
patients were evaluated by HyCoSy, a procedure that uses
aerated saline or contrast to assess tubal patency with
TVS. HyCoSy has been shown to be comparable to HSG
with regards to assessing tubal patency, with sensitiv-
ity ranges from 75–96 % and specificity from 67–100 %
[12, 13, 30, 31]. SIS and HyCoSy can be done in a single
visit and together provide information about the uterine
cavity and the patency of the fallopian tubes, similar to
HSG, but with added information about the myometrium
from the TVS component, all without exposure to ioniz-
ing radiation or iodinated contrast. Despite these advan-
tages, HyCoSy does not provide anatomical information
about the fallopian tubes, which limits its utility.
Given the lack of a single all encompassing imaging
tool for accurately diagnosing endometrial, tubal, and
myometrial causes of infertility, it could be helpful to
outline one step-wise approach for use of the TVS, HSG,
and HSC. Although there is tremendous variability be-
tween practices, at our institution most infertility pa-
tients undergo both a TVS and HSG prior to initiating
ART. Others have found that SIS and HyCoSy provide
comparable information as TVS and HSG combined. If
findings of these tests suggest an abnormality within the
uterine cavity, which could prevent implantation of a vi-
able gestational sac, the patient will be referred for a
HSC for direct inspection and possible treatment. How-
ever, the management of abnormal tubal pathology on
HSG will vary depending on plan for reproductive ther-
apy. If the patient is an In-vitro Fertilization (IVF) candi-
date, tubal obstruction is not of much consequence, as
the embryo is directly implanted into the uterus. However,
if the patient is not a candidate for IVF, tubal obstruction
can be further managed with surgical interventions such
as tuboplasty or salpingostomy.
Conclusion
Our study compared the results from TVS, HSG, and
HSC in a cohort of female infertility patients. TVS was
superior for detecting myometrial pathology, HSG was
superior for evaluating tubal patency, and HSC detected
Fig. 4 a 44 year-old G0P0 female with inability to conceive for 4 years presents for baseline assessment prior to IVF. TVS demonstrates an 11 ×
11 × 10 mm echogenic lesion within the left aspect of the endometrial cavity (calipers). Flow was demonstrated within the lesion with color
Doppler, raising the possibility of endometrial polyp. b Corresponding HSG demonstrates a depended rounded filling defect within the left
aspect of the endometrial cavity, which persisted on multiple projections, suggestive of a polyp. The fallopian tubes are normal in caliber and
patent. The patient went on to HSC, where the lesion proved to be a submucosal fibroid
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more endometrial polyps than HSG and TVS. No single
modality provided accurate identification of all different
pathologies. Complete work up of women with infertility
may include all modalities, given the unique information
obtained from each. However, with knowledge of the
unique specificity of each imaging test to detect specific
pathologies, a combination of HSG, HSC and TVS could
be selected based on the clinical presentation of patients.
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